Research and Development

Showing 15 posts of 9596 posts found.

teva_copy

More woes for Teva as two late-stage asthma studies bomb

January 23, 2018 Manufacturing and Production, Research and Development Teva, asthma, pharma

In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have …
nicolas_raymond

The measurement underpinning government goals for UK life sciences

January 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Industrial Strategy, brexit, john bell, life sciences, pharma

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …
gilead-sciences

Gilead aims to claim edge with Pfizer CAR-T combo

January 18, 2018 Medical Communications, Research and Development Gilead, Kite, Yescarta, biotech, drugs, pharma, pharmaceutical

Although those in pharma often dislike any references to drugs competing with each other for market as in a ‘race’, …
astrazeneca-sign

AstraZeneca expands drug discovery collaboration with X-Chem

January 18, 2018 Research and Development, Sales and Marketing AstraZeneca, X-Chem, pharma

AstraZeneca and X-Chem are to expand their existing drug discovery collaboration, it has emerged. The partnership marks the third agreement …
sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

January 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …
pregnancy_credit_needed

Evidence mounts yet again against efficacy of common morning sickness pill

January 18, 2018 Research and Development Diclegis, morning sickness, pharma

Evidence is mounting against the efficacy of the common morning sickness pill pyridoxine-doxylamine  (Diclegis, Diclectin), as new study data reveals …
blood-20745_960_720

Research calls for BRCA testing in all women

January 18, 2018 Medical Communications, Research and Development BRCA, biotech, drugs, pharma, pharmaceutical

For women, possessing a mutated BRCA1 or BRCA2 gene significantly increases the chances of developing breast or ovarian cancer; at …
cabometyx_tablets_60_mg_40_mg_20_mg

Ipsen ends P3 trial on liver cancer early due to strong data

January 18, 2018 Research and Development Cabometyx, Exelixis, biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into …
novartis_outside_1

Novartis’ CAR T therapy Kymriah scores accelerated approval in both Europe and US

January 17, 2018 Research and Development, Sales and Marketing CAR T, CAR-T, EMA, Europe, FDA, Kymriah, Novartis, US, pharma

Following up last year’s ground-breaking news that CAR T therapy Kymriah had become the first such treatment to be approved …
biodegradable_sensor

Fully biodegradable sensor offers safer way to monitor lung and brain conditions

January 17, 2018 Research and Development biodegradable sensor, pharma, university of connecticut

Engineers at the University of Connecticut have developed a biodegradable pressure sensor which is designed to, once ingested, aid in …
celgene_1_02

Celgene rumoured to be revving up for Juno buyout

January 17, 2018 Research and Development, Sales and Marketing CAR-T, Celgene, Juno, biotech, drugs, pharma, pharmaceutical

Celgene has already started off the year with a bang, announcing a deal with Impact Biomedicines worth a potential $7 …
aaeaaqaaaaaaaadzaaaajda2mmvkoduzltaxndctngywns1iztq3lwm3mtg3mzk0njnkyw

Digital solutions from Veeva’s European Commercial & Medical Summit

January 17, 2018 Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, veeva

When Peter Gassner, CEO and founder of Veeva, provided the keynote speech at the company’s European Commercial & Medical Summit, …
merckwindowweb

MSD’s interim Keytruda combo data spooks Roche and BMS

January 16, 2018 Research and Development MSD, Merck, biotech, drugs, keytruda, pharma, pharmaceutical

When PD-1/L1 treatments first came on the market, there was a race to snaffle as many indications as possible for …
filippo_6_for_internal_use_online

GSK Consumer Healthcare announces new Asia Pacific Regional Head

January 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline

GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …
The Gateway to Local Adoption Series

Latest content